Dow Up2.00% Nasdaq Up1.66%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
0.85 Up 0.04(4.75%) Feb 12, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development5,506  6,450  7,321  5,771  
Selling General and Administrative1,100  1,342  1,205  1,678  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (6,606) (7,792) (8,526) (7,449)
Income from Continuing Operations
Total Other Income/Expenses Net1  1  1  2  
Earnings Before Interest And Taxes(6,605)(7,791)(8,525)(7,447)
Interest Expense -   -   -   -  
Income Before Tax(6,605)(7,791)(8,525)(7,447)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,605)(7,791)(8,525)(7,447)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,605) (7,791) (8,525) (7,447)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,605) (7,791) (8,525) (7,447)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.